This patent provides kits for negatively depleting a population of cells so that what remains is hematopoietic stem cells. Different variants of this kit are sold by the Canadian company StemCell Technologies.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.